Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that Dave Lowrance, Chief Financial and Administrative ...
BOCA RATON, FL, June 08, 2026 (GLOBE NEWSWIRE) -- . (Nasdaq: DFDV) (the “Company”), the first US public company with a treasury strategy built to accumulate and compound ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. The CEO transition comes as Brady Corp. is in the process ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results